IL141158A0 - A humanized immunoglobulin which binds to human von willebrand factor - Google Patents

A humanized immunoglobulin which binds to human von willebrand factor

Info

Publication number
IL141158A0
IL141158A0 IL14115899A IL14115899A IL141158A0 IL 141158 A0 IL141158 A0 IL 141158A0 IL 14115899 A IL14115899 A IL 14115899A IL 14115899 A IL14115899 A IL 14115899A IL 141158 A0 IL141158 A0 IL 141158A0
Authority
IL
Israel
Prior art keywords
binds
von willebrand
willebrand factor
humanized immunoglobulin
human von
Prior art date
Application number
IL14115899A
Other languages
English (en)
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Publication of IL141158A0 publication Critical patent/IL141158A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL14115899A 1998-08-19 1999-08-19 A humanized immunoglobulin which binds to human von willebrand factor IL141158A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/136,315 US6228360B1 (en) 1998-08-19 1998-08-19 Antithrombotic agent and humanized anti-von Willebrand factor monoclonal antibody
PCT/US1999/016724 WO2000010601A1 (en) 1998-08-19 1999-08-19 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody

Publications (1)

Publication Number Publication Date
IL141158A0 true IL141158A0 (en) 2002-02-10

Family

ID=22472317

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14115899A IL141158A0 (en) 1998-08-19 1999-08-19 A humanized immunoglobulin which binds to human von willebrand factor
IL141158A IL141158A (en) 1998-08-19 2001-01-29 Human immunoglobulin that binds to the human willybrand factor

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL141158A IL141158A (en) 1998-08-19 2001-01-29 Human immunoglobulin that binds to the human willybrand factor

Country Status (17)

Country Link
US (4) US6228360B1 (xx)
EP (1) EP1112085B1 (xx)
JP (1) JP4590734B2 (xx)
KR (1) KR100693260B1 (xx)
CN (1) CN1259972C (xx)
AT (1) ATE476989T1 (xx)
AU (1) AU766500B2 (xx)
BR (1) BR9913084A (xx)
CA (1) CA2340466A1 (xx)
DE (1) DE69942668D1 (xx)
HU (1) HUP0103573A3 (xx)
IL (2) IL141158A0 (xx)
NO (1) NO20010747L (xx)
NZ (1) NZ509536A (xx)
RU (1) RU2223785C2 (xx)
WO (1) WO2000010601A1 (xx)
ZA (1) ZA200100939B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6228360B1 (en) * 1998-08-19 2001-05-08 Ajinomoto Co., Inc. Antithrombotic agent and humanized anti-von Willebrand factor monoclonal antibody
GB0031448D0 (en) * 2000-12-22 2001-02-07 Leuven K U Res & Dev Inhibition of the vWF-collagen interaction by anti-human vWF monoclonal antibody (82D6A3) results in abolition of in vivo arterial platelet thrombus formation
US8372798B2 (en) * 2001-10-16 2013-02-12 Endo Pharmaceuticals Colorado, Inc. High-concentration protein formulations and method of manufacture
JP2005298336A (ja) * 2002-01-29 2005-10-27 Ajinomoto Co Inc 炎症性疾患治療用薬剤
WO2004011030A1 (ja) * 2002-07-29 2004-02-05 Ajinomoto Co., Inc. 血小板減少症治療用医薬組成物
WO2004015425A1 (en) * 2002-08-07 2004-02-19 Umc Utrecht Holding B.V. Modulation of platelet adhesion based on the surface exposed beta-switch loop of platelet glycoprotein ib-alpha
NZ540771A (en) * 2003-01-10 2009-05-31 Ablynx Nv Recombinant VHH single domain antibody from camelidae against von willebrand factor (vWF) or against collagen
WO2005089285A2 (en) * 2004-03-15 2005-09-29 Biogen Idec Ma Inc. Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
WO2005099744A1 (en) * 2004-04-15 2005-10-27 Athera Biotechnologies Ab Annexin v for preventing atherothrombois and plaque rupture
CA2579374A1 (en) * 2004-09-07 2006-03-30 Archemix Corp. Aptamers to von willebrand factor and their use as thrombotic disease therapeutics
AU2004324464A1 (en) * 2004-10-22 2006-05-04 Applied Molecular Evolution, Inc. Methods of optimizing antibody variable region binding affinity
CA2593328C (en) * 2005-01-14 2018-02-06 Ablynx N.V. Methods and assays for distinguishing between different forms of diseases and disorders characterized by thrombocytopenia and/or by spontaneous interaction between von willebrand factor (vwf) and platelets
MX2007014564A (es) * 2005-05-20 2008-02-07 Ablynx Nv Anticuerpos de vhh de dominio unico contra el factor de von willebrand.
AR070141A1 (es) * 2008-01-23 2010-03-17 Glenmark Pharmaceuticals Sa Anticuerpos humanizados especificos para el factor von willebrand
CA2718081A1 (en) * 2008-03-21 2009-09-24 Ablynx Nv Von willebrand factor specific binders and methods of use therefor
JP2012517592A (ja) * 2009-02-06 2012-08-02 アスチュート メディカル，インコーポレイテッド 腎損傷および腎不全の診断および予後診断のための方法および組成物
US9229010B2 (en) 2009-02-06 2016-01-05 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN102532316B (zh) * 2010-12-24 2014-06-18 神州细胞工程有限公司 一种抗vWF单克隆抗体及其应用
EP3131929B1 (en) * 2014-04-16 2022-06-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Antibodies for the prevention or the treatment of bleeding episodes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704362A (en) 1977-11-08 1987-11-03 Genentech, Inc. Recombinant cloning vehicle microbial polypeptide expression
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB9020282D0 (en) * 1990-09-17 1990-10-31 Gorman Scott D Altered antibodies and their preparation
DE69233482T2 (de) * 1991-05-17 2006-01-12 Merck & Co., Inc. Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
US5777085A (en) * 1991-12-20 1998-07-07 Protein Design Labs, Inc. Humanized antibodies reactive with GPIIB/IIIA
KR0150060B1 (ko) * 1992-02-06 1998-08-17 에릭 에스. 딕커 사람 인터루킨-5에 대한 인간화 모노클로날 항체의 고안, 클로닝 및 발현
DE69334255D1 (de) * 1992-02-06 2009-02-12 Novartis Vaccines & Diagnostic Marker für Krebs und biosynthetisches Bindeprotein dafür
ES2197210T3 (es) * 1994-11-30 2004-01-01 Ajinomoto Co., Inc. Agente antitrombotico y anticuerpos monoclonales contra el factor von willebrand.
US6228360B1 (en) * 1998-08-19 2001-05-08 Ajinomoto Co., Inc. Antithrombotic agent and humanized anti-von Willebrand factor monoclonal antibody

Also Published As

Publication number Publication date
WO2000010601A1 (en) 2000-03-02
US20030180293A1 (en) 2003-09-25
CN1311691A (zh) 2001-09-05
KR20010072749A (ko) 2001-07-31
BR9913084A (pt) 2001-05-08
RU2223785C2 (ru) 2004-02-20
ZA200100939B (en) 2001-09-03
HUP0103573A2 (hu) 2002-01-28
KR100693260B1 (ko) 2007-03-13
JP2002523379A (ja) 2002-07-30
US20030064068A1 (en) 2003-04-03
ATE476989T1 (de) 2010-08-15
EP1112085B1 (en) 2010-08-11
US6613328B2 (en) 2003-09-02
CA2340466A1 (en) 2000-03-02
US7138116B2 (en) 2006-11-21
EP1112085A1 (en) 2001-07-04
US6228360B1 (en) 2001-05-08
NO20010747L (no) 2001-04-03
CN1259972C (zh) 2006-06-21
NO20010747D0 (no) 2001-02-14
AU5668099A (en) 2000-03-14
US7311913B2 (en) 2007-12-25
AU766500B2 (en) 2003-10-16
US20050197494A1 (en) 2005-09-08
JP4590734B2 (ja) 2010-12-01
EP1112085A4 (en) 2002-11-20
DE69942668D1 (de) 2010-09-23
IL141158A (en) 2006-04-10
HUP0103573A3 (en) 2003-09-29
NZ509536A (en) 2002-11-26

Similar Documents

Publication Publication Date Title
IL141158A0 (en) A humanized immunoglobulin which binds to human von willebrand factor
DK1516629T3 (da) Humaniseret anti-CD-11a antibodies
EP0724456A4 (en) ANTIBODIES AGAINST CD40
HK1020990A1 (en) Antibodies to the ed-b domain of fibronectin, their construction and uses
PT804237E (pt) Anticorpos humanizados contra a molecula de adesao leucocitaria vla-4
EE200100336A (et) CTLA-4 vastased inimese monoklonaalsed antikehad
EE05627B1 (et) CTLA-4 vastased inimese monoklonaalsed antikehad
UA89017C2 (uk) ЛЮДСЬКЕ АНТИТІЛО, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ЛЮДСЬКИМ TNFSF13b
IL130864A0 (en) Monoclonal antibodies to human cd6
PT719859E (pt) Anticorpo monoclonal anti-alfa v-integrina
FI970198A0 (fi) Ihmisen immuunikatoviruksen vastaiset neutraloivat ihmisen monoklonaaliset vasta-aineet
AU6954398A (en) Antagonistic anti-avb3 integrin antibodies
ES2173130T3 (es) Metodo de fijacion de material al peptido beta-amiloide.
NO20004251D0 (no) Humaniserte anti-CEA monoklonale antistoffer med høy affinitet
AU6568996A (en) Peptide ligands which bind to von Willebrand factor
DK49291D0 (da) Gramnegativ-bakterieendotoxinblokerende, monoklonale antistoffer
GB9718911D0 (en) Monoclonal antibodies
BR1100555B1 (pt) anticorpos monoclonais humanizados.
NO985281D0 (no) Monoklonalt antihumant MP52-antistoff
AU2003200933A1 (en) Conformation-specific Anti-von Willebrand Factor Antibodies
ZA937033B (en) Reshaped monoclonal antibodies against an immunoglobulin isotype.
SI0742795T1 (en) Immuno-stimulatory monoclonal antibodies
IL125204A0 (en) Anti-bacterial monoclonal antibodies
DE69324928T2 (de) Monoklonaler antikörper
GB9615027D0 (en) Monoclonal antibodies

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed